Barbara Jereczek-Fossa, Full Professor of Radiation Oncology at Milan University, shared a post by JAMA Network Open on LinkedIn, adding:
“An important start to the New Year!
This meta-analysis adds further evidence supporting the role of radiotherapy within a personalized, multidisciplinary approach to cancer care: a reassuring message for daily clinical practice.
Wishing everyone a meaningful New Year, with heartfelt thanks to our patients, their caregivers, volunteers, and all colleagues worldwide who make progress possible.”
Quoting JAMA Network Open’s post:
“In this systematic review and meta-analysis, metastasis-directed SBRT alone was associated with meaningful STFS, particularly in patients with oligometastatic prostate or renal cell cancer, with low risks of treatment-related adverse events.”
Title: Stereotactic Body Radiotherapy Without Systemic Therapy for Oligometastatic Cancer
Authors: Jonas Willmann, Camilla von Wachter, Ronja Zehnder
Read the full article.
More posts featuring Radiation Oncology on OncoDaily.